EMILY KEEN: Open Payments
NPI 1104336189 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 14 payments from 8 companies in 2025. Trend: 2023 $206 · 2024 $571 · 2025 $855
Food & beverage: $855
| Company | Payments | Amount |
|---|---|---|
| ARGENX US, INC. | 2 | $212 |
| Amgen Inc. | 5 | $191 |
| Lundbeck LLC | 2 | $135 |
| Teva Pharmaceuticals USA, Inc. | 1 | $99 |
| PFIZER INC. | 1 | $90 |
| Dynavax Technologies Corporation | 1 | $75 |
| Genentech USA, Inc. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
Products named: VYVGART, KRYSTEXXA, VYEPTI, AUSTEDO XR, ABRYSVO, Heplisav-B, Ocrevus Zunovo, TEZSPIRE.
Industry payments across CO — which companies pay providers there.
